Cite

HARVARD Citation

    Chen, C. et al. (2019). Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma. Medicine. 98 (32), p. . [Online]. 
  
Back to record